Cargando…

Impact of diabetes on surgery and radiotherapy for breast cancer

PURPOSES: This study aims to examine whether diabetes has an impact on the use of surgery and adjuvant radiotherapy in treating women with localised breast cancer. METHODS: Women diagnosed with stage I–III breast cancer between 2005 and 2020 were identified from Te Rēhita Mate Ūtaetae—Breast Cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Lawrenson, Ross, Lao, Chunhuan, Stanley, James, Campbell, Ian, Krebs, Jeremy, Meredith, Ineke, Koea, Jonathan, Teng, Andrea, Sika-Paotonu, Dianne, Stairmand, Jeannine, Gurney, Jason
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175479/
https://www.ncbi.nlm.nih.gov/pubmed/36997750
http://dx.doi.org/10.1007/s10549-023-06915-1
_version_ 1785040220584935424
author Lawrenson, Ross
Lao, Chunhuan
Stanley, James
Campbell, Ian
Krebs, Jeremy
Meredith, Ineke
Koea, Jonathan
Teng, Andrea
Sika-Paotonu, Dianne
Stairmand, Jeannine
Gurney, Jason
author_facet Lawrenson, Ross
Lao, Chunhuan
Stanley, James
Campbell, Ian
Krebs, Jeremy
Meredith, Ineke
Koea, Jonathan
Teng, Andrea
Sika-Paotonu, Dianne
Stairmand, Jeannine
Gurney, Jason
author_sort Lawrenson, Ross
collection PubMed
description PURPOSES: This study aims to examine whether diabetes has an impact on the use of surgery and adjuvant radiotherapy in treating women with localised breast cancer. METHODS: Women diagnosed with stage I–III breast cancer between 2005 and 2020 were identified from Te Rēhita Mate Ūtaetae—Breast Cancer Foundation New Zealand National Register, with diabetes status determined using New Zealand’s Virtual Diabetes Register. The cancer treatments examined included breast conserving surgery (BCS), mastectomy, breast reconstruction after mastectomy, and adjuvant radiotherapy after BCS. Logistic regression modelling was used to estimate the adjusted odds ratio (OR) and 95% confidence interval (95% CI) of having cancer treatment and treatment delay (> 31 days) for patients with diabetes at the time of cancer diagnosis compared to patients without diabetes. RESULTS: We identified 25,557 women diagnosed with stage I–III breast cancer in 2005–2020, including 2906 (11.4%) with diabetes. After adjustment for other factors, there was no significant difference overall in risk of women with diabetes having no surgery (OR 1.12, 95% CI 0.94–1.33), although for patients with stage I disease not having surgery was more likely (OR 1.45, 95% CI 1.05–2.00) in the diabetes group. Patients with diabetes were more likely to have their surgery delayed (adjusted OR of 1.16, 95% CI 1.05–1.27) and less likely to have reconstruction after mastectomy compared to the non-diabetes group—adjusted OR 0.54 (95% CI 0.35–0.84) for stage I cancer, 0.50 (95% CI 0.34–0.75) for stage II and 0.48 (95% CI 0.24–1.00) for stage III cancer. CONCLUSIONS: Diabetes is associated with a lower likelihood of receiving surgery and a greater delay to surgery. Women with diabetes are also less likely to have breast reconstruction after mastectomy. These differences need to be taken in to account when considering factors that may impact on the outcomes of women with diabetes especially for Māori, Pacific and Asian women.
format Online
Article
Text
id pubmed-10175479
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-101754792023-05-13 Impact of diabetes on surgery and radiotherapy for breast cancer Lawrenson, Ross Lao, Chunhuan Stanley, James Campbell, Ian Krebs, Jeremy Meredith, Ineke Koea, Jonathan Teng, Andrea Sika-Paotonu, Dianne Stairmand, Jeannine Gurney, Jason Breast Cancer Res Treat Epidemiology PURPOSES: This study aims to examine whether diabetes has an impact on the use of surgery and adjuvant radiotherapy in treating women with localised breast cancer. METHODS: Women diagnosed with stage I–III breast cancer between 2005 and 2020 were identified from Te Rēhita Mate Ūtaetae—Breast Cancer Foundation New Zealand National Register, with diabetes status determined using New Zealand’s Virtual Diabetes Register. The cancer treatments examined included breast conserving surgery (BCS), mastectomy, breast reconstruction after mastectomy, and adjuvant radiotherapy after BCS. Logistic regression modelling was used to estimate the adjusted odds ratio (OR) and 95% confidence interval (95% CI) of having cancer treatment and treatment delay (> 31 days) for patients with diabetes at the time of cancer diagnosis compared to patients without diabetes. RESULTS: We identified 25,557 women diagnosed with stage I–III breast cancer in 2005–2020, including 2906 (11.4%) with diabetes. After adjustment for other factors, there was no significant difference overall in risk of women with diabetes having no surgery (OR 1.12, 95% CI 0.94–1.33), although for patients with stage I disease not having surgery was more likely (OR 1.45, 95% CI 1.05–2.00) in the diabetes group. Patients with diabetes were more likely to have their surgery delayed (adjusted OR of 1.16, 95% CI 1.05–1.27) and less likely to have reconstruction after mastectomy compared to the non-diabetes group—adjusted OR 0.54 (95% CI 0.35–0.84) for stage I cancer, 0.50 (95% CI 0.34–0.75) for stage II and 0.48 (95% CI 0.24–1.00) for stage III cancer. CONCLUSIONS: Diabetes is associated with a lower likelihood of receiving surgery and a greater delay to surgery. Women with diabetes are also less likely to have breast reconstruction after mastectomy. These differences need to be taken in to account when considering factors that may impact on the outcomes of women with diabetes especially for Māori, Pacific and Asian women. Springer US 2023-03-30 2023 /pmc/articles/PMC10175479/ /pubmed/36997750 http://dx.doi.org/10.1007/s10549-023-06915-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Epidemiology
Lawrenson, Ross
Lao, Chunhuan
Stanley, James
Campbell, Ian
Krebs, Jeremy
Meredith, Ineke
Koea, Jonathan
Teng, Andrea
Sika-Paotonu, Dianne
Stairmand, Jeannine
Gurney, Jason
Impact of diabetes on surgery and radiotherapy for breast cancer
title Impact of diabetes on surgery and radiotherapy for breast cancer
title_full Impact of diabetes on surgery and radiotherapy for breast cancer
title_fullStr Impact of diabetes on surgery and radiotherapy for breast cancer
title_full_unstemmed Impact of diabetes on surgery and radiotherapy for breast cancer
title_short Impact of diabetes on surgery and radiotherapy for breast cancer
title_sort impact of diabetes on surgery and radiotherapy for breast cancer
topic Epidemiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175479/
https://www.ncbi.nlm.nih.gov/pubmed/36997750
http://dx.doi.org/10.1007/s10549-023-06915-1
work_keys_str_mv AT lawrensonross impactofdiabetesonsurgeryandradiotherapyforbreastcancer
AT laochunhuan impactofdiabetesonsurgeryandradiotherapyforbreastcancer
AT stanleyjames impactofdiabetesonsurgeryandradiotherapyforbreastcancer
AT campbellian impactofdiabetesonsurgeryandradiotherapyforbreastcancer
AT krebsjeremy impactofdiabetesonsurgeryandradiotherapyforbreastcancer
AT meredithineke impactofdiabetesonsurgeryandradiotherapyforbreastcancer
AT koeajonathan impactofdiabetesonsurgeryandradiotherapyforbreastcancer
AT tengandrea impactofdiabetesonsurgeryandradiotherapyforbreastcancer
AT sikapaotonudianne impactofdiabetesonsurgeryandradiotherapyforbreastcancer
AT stairmandjeannine impactofdiabetesonsurgeryandradiotherapyforbreastcancer
AT gurneyjason impactofdiabetesonsurgeryandradiotherapyforbreastcancer